Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans.

Koch-Heier, Julia; Schönsiegel, Annika; Waidele, Lara Maria; Volk, Julian; Füll, Yvonne; Wallasch, Christian; Canisius, Sebastian; Burnet, Michael; Planz, Oliver.

Afiliação

Koch-Heier J; Department of Immunology, Interfaculty Institute for Cell Biology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Schönsiegel A; Atriva Therapeutics GmbH, Tuebingen, Germany.
Waidele LM; Department of Immunology, Interfaculty Institute for Cell Biology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Volk J; Atriva Therapeutics GmbH, Tuebingen, Germany.
Füll Y; Department of Immunology, Interfaculty Institute for Cell Biology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Wallasch C; Atriva Therapeutics GmbH, Tuebingen, Germany.
Canisius S; Department of Immunology, Interfaculty Institute for Cell Biology, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Burnet M; Atriva Therapeutics GmbH, Tuebingen, Germany.
Planz O; Atriva Therapeutics GmbH, Tuebingen, Germany.